Mirum Pharmaceuticals Inc (NASDAQ: MIRM) kicked off on Friday, up 0.36% from the previous trading day, before settling in for the closing price of $39.32. Over the past 52 weeks, MIRM has traded in a range of $23.14-$45.23.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 88.90%. While this was happening, its average annual earnings per share was recorded 53.62%. With a float of $38.04 million, this company’s outstanding shares have now reached $46.72 million.
Let’s determine the extent of company efficiency that accounts for 264 employees. In terms of profitability, gross margin is 73.13%, operating margin of -40.07%, and the pretax margin is -39.69%.
Mirum Pharmaceuticals Inc (MIRM) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Mirum Pharmaceuticals Inc is 20.26%, while institutional ownership is 95.88%. The most recent insider transaction that took place on Sep 18 ’24, was worth 4,301. In this transaction Director of this company bought 115 shares at a rate of $37.40, taking the stock ownership to the 162,308 shares. Before that another transaction happened on Sep 06 ’24, when Company’s Director bought 230 for $41.58, making the entire transaction worth $9,563. This insider now owns 162,193 shares in total.
Mirum Pharmaceuticals Inc (MIRM) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 53.62% per share during the next fiscal year.
Mirum Pharmaceuticals Inc (NASDAQ: MIRM) Trading Performance Indicators
Take a look at Mirum Pharmaceuticals Inc’s (MIRM) current performance indicators. Last quarter, stock had a quick ratio of 3.09. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 7.12.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.34, a number that is poised to hit -0.45 in the next quarter and is forecasted to reach -0.87 in one year’s time.
Technical Analysis of Mirum Pharmaceuticals Inc (MIRM)
Looking closely at Mirum Pharmaceuticals Inc (NASDAQ: MIRM), its last 5-days average volume was 0.31 million, which is a drop from its year-to-date volume of 0.58 million. As of the previous 9 days, the stock’s Stochastic %D was 65.64%. Additionally, its Average True Range was 1.41.
During the past 100 days, Mirum Pharmaceuticals Inc’s (MIRM) raw stochastic average was set at 73.04%, which indicates a significant increase from 36.93% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 36.29% in the past 14 days, which was lower than the 64.23% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $40.56, while its 200-day Moving Average is $31.87. However, in the short run, Mirum Pharmaceuticals Inc’s stock first resistance to watch stands at $40.14. Second resistance stands at $40.83. The third major resistance level sits at $41.31. If the price goes on to break the first support level at $38.97, it is likely to go to the next support level at $38.49. Should the price break the second support level, the third support level stands at $37.80.
Mirum Pharmaceuticals Inc (NASDAQ: MIRM) Key Stats
The company with the Market Capitalisation of 1.88 billion has total of 47,133K Shares Outstanding. Its annual sales at the moment are 186,370 K in contrast with the sum of -163,420 K annual income. Company’s last quarter sales were recorded 77,880 K and last quarter income was -24,640 K.
